The prevalence of MVP in malignant cells suggests a potential role in shaping the immune microenvironment of PAAD, highlighting the urgent need for future studies to dissect the molecular mechanisms underlying this interaction. This evidence concerns the gene MVP and pancreatic adenocarcinoma.